Hughes RS, Frenkel EP (1997) The role of chemotherapy in head and neck cancer. Am J Clin Oncol 20(5)

Vermorken JB, Mesia R, Rivera F, Remenar E, Kawecki A, Rottey S, Erfan J, Zabolotnyy D, Kienzer HR, Cupissol D et al (2008) Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 359:1116–1143

Article  CAS  PubMed  Google Scholar 

Burtness B, Harrington KJ, Greil R, Soulières D, Tahara M, de Castro G Jr, Psyrri A, Basté N, Neupane P, Bratland Å et al (2019) Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. Lancet 394(10212):1915–1928. https://doi.org/10.1016/S0140-6736(19)32591-7

Article  CAS  PubMed  Google Scholar 

Harrington KJ, Burtness B, Greil R, Soulières D, Tahara M, De Castro G, Psyrri A, Brana I, Basté N, Neupane P et al (2023) Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: Updated results of the Phase III KEYNOTE-048 study. J Clin Oncol 41(4):790–802

Article  CAS  PubMed  Google Scholar 

Hellman S, Weichselbaum RR (2016) Oligometastases. J Clin Oncol 13(1):8–10

Article  Google Scholar 

Lievens Y, Guckenberger M, Gomez D, Hoyer M, Iyengar P, Kindts I, Méndez Romero A, Nevens D, Palma D, Park C et al (2020) Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document. Radiother Oncol 148:157–166

Article  PubMed  Google Scholar 

Guckenberger M, Lievens Y, Bouma AB, Collette L, Dekker A, deSouza NM, Dingemans AMS, Fournier B, Hurkmans C, Lecouvet FE et al (2020) Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation. Lancet Oncol 21(1):e18–28

Article  PubMed  Google Scholar 

Guckenberger M, Andratschke N, Alheit H, Holy R, Moustakis C, Nestle U, Sauer O (2014) Definition of stereotactic body radiotherapy: Principles and practice for the treatment of stage I non-small cell lung cancer. Strahlentherapie und Onkol 190(1):26–33

Article  CAS  Google Scholar 

Guckenberger M, Baus WW, Blanck O, Combs SE, Debus J, Engenhart-Cabillic R, Gauer T, Grosu AL, Schmitt D, Tanadini-Lang S et al (2020) Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery. Strahlentherapie 196(5):417–420. https://doi.org/10.1007/s00066-020-01603-1

Article  Google Scholar 

Chang JY, Mehran RJ, Feng L, Verma V, Liao Z, Welsh JW, Lin SH, O’Reilly MS, Jeter MD, Balter PA et al (2021) Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery. Lancet Oncol 22(10):1448–1457. https://doi.org/10.1016/S1470-2045(21)00401-0

Article  PubMed  PubMed Central  Google Scholar 

Kimura T, Takeda A, Sanuki N, Ariyoshi K, Yamaguchi T, Imagumbai T, Katoh N, Eriguchi T, Oku Y, Ozawa S et al (2021) Multicenter prospective study of stereotactic body radiotherapy for previously untreated solitary primary hepatocellular carcinoma: The STRSPH study. Hepatol Res 51(4):461–471. https://doi.org/10.1111/hepr.13595

Article  PubMed  Google Scholar 

Gomez DR, Tang C, Zhang J, Blumenschein GR, Hernandez M, Jack Lee J, Ye R, Palma DA, Louie AV, Ross Camidge D et al (2019) Local consolidative therapy vs. Maintenance therapy or observation for patients with oligometastatic non–small-cell lung cancer: Long-term results of a multi-institutional, phase II, randomized study. J Clin Oncol 8;37(18):1558–1565

Article  PubMed  Google Scholar 

Palma DA, Olson R, Harrow S, Gaede S, Louie AV, Haasbeek C, Mulroy L, Lock M, Rodrigues GB, Yaremko BP et al (2019) Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet 393(10185):2051–2058. https://doi.org/10.1016/S0140-6736(18)32487-5

Article  PubMed  Google Scholar 

Willmann J, Vlaskou Badra E, Adilovic S, Christ SM, Ahmadsei M, Mayinger M, Guckenberger M, Andratschke N (2022) Stereotactic body radiotherapy to defer systemic therapy in patients with oligorecurrent disease. Clin Transl Radiat Oncol 37:12–18

CAS  PubMed  PubMed Central  Google Scholar 

Nicosia L, Cuccia F, Mazzola R, Ricchetti F, Figlia V, Giaj-Levra N, Rigo M, Tomasini D, Pasinetti N, Corradini S et al (2020) Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy. Strahlentherapie und Onkol 196(9):813–820. https://doi.org/10.1007/s00066-020-01627-7

Article  Google Scholar 

Wise-Draper TM, Bahig H, Tonneau M, Karivedu V, Burtness B (2022) Current therapy for metastatic head and neck cancer: Evidence, opportunities, and challenges. Am Soc Clin Oncol Educ book Am Soc Clin Oncol Annu Meet 42(42):1–14

Google Scholar 

Faulhaber EM, Jost T, Symank J, Scheper J, Bürkel F, Fietkau R, Hecht M, Distel LV (2021) Kinase inhibitors of dna-pk, atm and atr in combination with ionizing radiation can increase tumor cell death in hnscc cells while sparing normal tissue cells. Genes (basel) 12(6)

Hecht M, Eckstein M, Kallies A, Klautke G, Illmer T, von der Grün J, Laban S, Hautmann MG, Tamaskovics B, Brunner T et al (2022) Pathologic response after induction chemo-immunotherapy with single or double immune checkpoint inhibition in locally advanced head and neck squamous cell carcinoma (HNSCC): Expansion cohorts of the CheckRad-CD8 trial. J Clin Oncol 40(16_suppl):6064–6064

Article  Google Scholar 

Sari SY, Yilmaz MT, Aktas BY, Aksoy S, Gullu I, Cengiz M, Ozyigit G, Yazici G (2022) Results of concurrent radiotherapy and immunotherapy in recurrent and metastatic head and neck cancer: A single-center experience. Oral Oncol 124(105658)

Wilke L, Andratschke N, Blanck O, Brunner TB, Combs SE, Grosu AL, Moustakis C, Schmitt D, Baus WW, Guckenberger M (2019) ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams: Statement from the DEGRO/DGMP working group stereotactic radiotherapy and radiosurgery. Strahlentherapie und Onkol 195(3):193–198. https://doi.org/10.1007/s00066-018-1416-x

Article  Google Scholar 

Phillips R, Shi WY, Deek M, Radwan N, Lim SJ, Antonarakis ES, Rowe SP, Ross AE, Gorin MA, Deville C et al (2020) Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: The ORIOLE Phase 2 Randomized Clinical Trial. JAMA Oncol 6(5):650–659

Article  PubMed  PubMed Central  Google Scholar 

Bonomo P, Greto D, Desideri I, Loi M, Di Cataldo V, Orlandi E, Iacovelli NA, Becherini C, Visani L, Salvestrini V et al (2019) Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal? Oral Oncol 93:1–7

Article  PubMed  Google Scholar 

Bates JE, De Leo AN, Morris CG, Amdur RJ, Dagan R (2019) Oligometastatic squamous cell carcinoma of the head and neck treated with stereotactic body ablative radiotherapy: Single-institution outcomes. Head Neck 41(7):2309–2314. https://doi.org/10.1002/hed.25695

Article  PubMed  Google Scholar 

Weissmann T, Höfler D, Hecht M, Semrau S, Haderlein M, Filimonova I, Frey B, Bert C, Lettmaier S, Mantsopoulos K et al (2021) Oligometastatic head and neck cancer: Which patients benefit from radical local treatment of all tumour sites? Radiat Oncol. https://doi.org/10.1186/s13014-021-01790-w

Article  PubMed  PubMed Central  Google Scholar 

Pasalic D, Betancourt-Cuellar SL, Taku N, Ludmir EB, Lu Y, Allen PK, Tang C, Antonoff MB, Fuller CD, Rosenthal DI et al (2020) Outcomes and toxicities following stereotactic ablative radiotherapy for pulmonary metastases in patients with primary head and neck cancer. Head Neck 42(8):1939–1953

Article  PubMed  PubMed Central  Google Scholar 

Franzese C, Badalamenti M, Teriaca A, De Virgilio A, Mercante G, Cavina R, Ferrari D, Santoro A, Spriano G, Scorsetti M (2021) Metastasis-directed stereotactic body radiation therapy in the management of oligometastatic head and neck cancer. J Cancer Res Clin Oncol 147(5):1307–1313. https://doi.org/10.1007/s00432-021-03518-5

Article  CAS  PubMed  Google Scholar 

Fakhry C, Zhang Q, Nguyen-Tan PF, Rosenthal D, El-Naggar A, Garden AS, Soulieres D, Trotti A, Avizonis V, Ridge JA et al (2014) Human Papillomavirus and Overall Survival After Progression of Oropharyngeal Squamous Cell Carcinoma. J Clin Oncol 32(30):3365

Article  PubMed  PubMed Central  Google Scholar